Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lowes | LOW | Oct 30, 2024 | 261.39 | -0.60 |
LPL Financial | LPLA | Oct 30, 2024 | 264.02 | -0.61 |
LQR House | LQR | Oct 30, 2024 | 0.76 | +2.47 |
LSB Industries | LXU | Oct 30, 2024 | 8.18 | -2.85 |
LSI Industries | LYTS | Oct 30, 2024 | 16.49 | -0.12 |
Ltc Properties | LTC | Oct 30, 2024 | 39.00 | +2.42 |
Lucas GC | LGCL | Oct 30, 2024 | 1.15 | +5.50 |
Lucid Diagnostics | LUCD | Oct 30, 2024 | 1.00 | +1.57 |
Lucid Group | LCID | Oct 30, 2024 | 2.35 | -3.69 |
Lufax ADR | LU | Oct 30, 2024 | 2.60 | -1.89 |
Lululemon Athletica | LULU | Oct 30, 2024 | 303.85 | -0.32 |
Lulus Fashion Lounge | LVLU | Oct 30, 2024 | 1.50 | -3.23 |
Lumen Technologies | LUMN | Oct 30, 2024 | 6.69 | +1.36 |
Lument Finance Trust | LFT | Oct 30, 2024 | 2.50 | 0.00 |
Lument Finance Trust A Pref | LFT-A | Oct 30, 2024 | 23.00 | +0.44 |
Lumentum | LITE | Oct 30, 2024 | 65.35 | -0.62 |
Luminar Technologies A | LAZR | Oct 30, 2024 | 0.86 | -3.40 |
Lumos Pharma | LUMO | Oct 30, 2024 | 4.34 | -0.69 |
Luna Innovations | LUNA | Oct 30, 2024 | 1.54 | -9.68 |
Luokung Technology | LKCO | Oct 30, 2024 | 1.90 | -7.32 |
Luxfer | LXFR | Oct 30, 2024 | 14.59 | +14.43 |
LuxUrban Hotels | LUXH | Oct 30, 2024 | 0.04 | -14.46 |
Luxurban Hotels Pref | LUXHP | Oct 30, 2024 | 14.08 | -2.90 |
Lxp Industrial Trust | LXP | Oct 30, 2024 | 9.48 | +1.07 |
LXP Industrial Trust C Pref | LXP-C | Oct 30, 2024 | 52.20 | +1.91 |
Lyell Immunopharma | LYEL | Oct 30, 2024 | 0.86 | -9.47 |
Lyft A | LYFT | Oct 30, 2024 | 13.67 | -1.73 |
LyondellBasell Industries Nv A | LYB | Oct 30, 2024 | 87.15 | -0.03 |
Lyra Therapeutics | LYRA | Oct 30, 2024 | 0.27 | +2.83 |
Lytus Technologies | LYT | Oct 30, 2024 | 1.78 | -3.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.